D Milligan

4.3k citations

62 papers · 3.0k indexed · 1 hit paper · h-index 26

Impact in

Hematology top 0.5%
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
Genetics top 0.5%
- Chronic Lymphocytic Leukemia Research

Papers in ⓘ

Hematology 27
- Acute Myeloid Leukemia Research 12
- Hematopoietic Stem Cell Transplantation 12
- Chronic Myeloid Leukemia Treatments 6
Genetics 21
- Chronic Lymphocytic Leukemia Research 16

Co-authors: Barry W. Hancock (5 shared papers)G. Vaughan Hudson (4 shared papers)David C. Linch (4 shared papers)D.A. Winfield (2 shared papers)A. H. Goldstone (2 shared papers)D. J. Moir (1 shared paper)Rajesh Chopra (1 shared paper)Annabel McMillan (1 shared paper)
Journals: Leukemia (9 papers)British Journal of Haematology (7 papers)Bone Marrow Transplantation (6 papers)Journal of Clinical Pathology (5 papers)Psycho-Oncology (2 papers)
Partner nations: United Kingdom Germany France

In The Last Decade

D Milligan

60 papers receiving 2.9k citations

Hit Papers

align trajectories log scale

Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trial 1993 · 768 citations

Peers

Countries citing papers authored by D Milligan

Since Specialization

Citations

This map shows the geographic impact of D Milligan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D Milligan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D Milligan more than expected).

Fields of papers citing papers by D Milligan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D Milligan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D Milligan. The network helps show where D Milligan may publish in the future.

Co-authors

The 25 scholars most cited alongside D Milligan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with D Milligan Line = papers co-authored together D Milligan links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 62 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trial The Lancet ·David C. Linch, A. H. Goldstone, Annabel McMillan, Rajesh Chopra, G. Vaughan Hudson, D.A. Winfield, Barry W. Hancock, D. J. Moir, D Milligan Hit paper breakdown →	1993	768
2	Indications for allogeneic stem cell transplantation in chronic lymphocytic leukemia: the EBMT transplant consensus Leukemia ·Peter Dreger, Paolo Corradini, Eva Kimby, Mauricette Michallet, D Milligan, Johannes Schetelig, W Wiktor-Jędrzejczak, Dietger Niederwieser, Michael Hallek, Emili Montserrat, (unknown)	2006	236
3	Update of guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen Clinical Medicine ·J. M. Davies, Rosemary A. Barnes, D Milligan	2002	183
4	Treatment-related mortality and graft-versus-leukemia activity after allogeneic stem cell transplantation for chronic lymphocytic leukemia using intensity-reduced conditioning Leukemia ·Peter Dreger, R. Brand, J Hansz, D Milligan, Paolo Corradini, Jürgen Finke, G Lambertenghi Deliliers, Rodrigo Martino, Nigel H. Russell, Anja van Biezen, Mauricette Michallet, Dietger Niederwieser, (unknown)	2003	137
5	The addition of gemtuzumab ozogamicin to low-dose Ara-C improves remission rate but does not significantly prolong survival in older patients with acute myeloid leukaemia: results from the LRF AML14 and NCRI AML16 pick-a-winner comparison Leukemia ·Alan K. Burnett, Robert K. Hills, Ann E. Hunter, D Milligan, William J. Kell, Keith Wheatley, J. A. Liu Yin, Mary Frances McMullin, Helen Dignum, David Bowen, Nigel H. Russell	2012	124
6	Reduced-intensity conditioning lowers treatment-related mortality of allogeneic stem cell transplantation for chronic lymphocytic leukemia: a population-matched analysis Leukemia ·Peter Dreger, R. Brand, D Milligan, Paolo Corradini, Jürgen Finke, G Lambertenghi Deliliers, Rodrigo Martino, Nigel H. Russell, Anja van Biezen, Mauricette Michallet, Dietger Niederwieser, (unknown)	2005	107
7	Guidelines on the diagnosis and management of chronic lymphocytic leukaemia British Journal of Haematology ·David Oscier, Chris Fegan, Peter Hillmen, Tim Illidge, Stephen A. Johnson, Patrick D. Maguire, Estella Matutes, D Milligan	2004	106
8	Guidelines on the management of acute myeloid leukaemia in adults British Journal of Haematology ·D Milligan, David Grimwade, Jonathan Cullis, Laura Bond, David Swirsky, Charles Craddock, Jonathan Kell, Janis Homewood, Kenneth L. Campbell, Susan McGinley, Keith Wheatley, G Jackson	2006	102
9	Quality of life in long-term survivors of marrow transplantation: comparison with a matched group receiving maintenance chemotherapy. PubMed ·Alex Molassiotis, Olga van den Akker, D Milligan, John M. Goldman, B. J. Boughton, J. A. Holmes, Simon Thomas	1996	80
10	Symptom distress, coping style and biological variables as predictors of survival after bone marrow transplantation Journal of Psychosomatic Research ·Alex Molassiotis, Olga van den Akker, D Milligan, J M Goldman	1997	80
11	Outcome of second allogeneic transplants using reduced-intensity conditioning following relapse of haematological malignancy after an initial allogeneic transplant Bone Marrow Transplantation ·Bronwen E. Shaw, G J Mufti, Stephen Mackinnon, Jamie Cavenagh, Rachel M. Pearce, K. Towlson, Jane F. Apperley, Ronjon Chakraverty, Charles Craddock, M Kazmi, Tim Littlewood, D Milligan, Antonio Pagliuca, Kirsty Thomson, D I Marks, Nigel H. Russell	2008	76
12	Allogeneic peripheral blood stem cell transplantation for haematological malignancies – an analysis of kinetics of engraftment and GVHD risk Bone Marrow Transplantation ·Gail Miflin, NH Russell, R. M. Hutchinson, Gareth J. Morgan, Michael Potter, Antonio Pagliuca, Judith Marsh, A.J. Bell, D Milligan, Matthew Lumley, Gordon Cook, Ian M. Franklin	1997	75
13	High-dose therapy and autologous stem cell rescue for patients with Hodgkin’s disease in first relapse after chemotherapy: results from the EBMT Bone Marrow Transplantation ·J. Sweetenham, G. Taghipour, D Milligan, AK Blystad, Dolores Caballero, Αthanasios Fassas, AH Goldstone, (unknown)	1997	67
14	Role of non-transferrin bound iron in iron overload and liver dysfunction in long term survivors of acute leukaemia and bone marrow transplantation. Journal of Clinical Pathology ·Paul Harrison, Jeffrey R. Neilson, Sukhjinder Marwah, Lisa Madden, D. Bareford, D Milligan	1996	47
15	Pseudomembranous colitis in a leukaemia unit: a report of five fatal cases. Journal of Clinical Pathology ·D Milligan, J Kelly	1979	41
16	High-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin’s disease is unlikely to be associated with a major increased risk of secondary MDS/AML British Journal of Cancer ·Claire Harrison, Walter M. Gregory, G. Vaughan Hudson, Stephen Devereux, Anthony H. Goldstone, Barry W. Hancock, D.A. Winfield, A K MacMillan, Peter Hoskin, Adrian C. Newland, D Milligan, David C. Linch	1999	40
17	Parainfluenza Virus Type 3 Infections in Hematopoetic Stem Cell Transplant Recipients: Response to Ribavirin Therapy Clinical Infectious Diseases ·Suparno Chakrabarti, K.E. Collingham, Kathleen Holder, S. M. OYAIDE, Deenan Pillay, D Milligan	2000	39
18	Gonadal function and psychosexual adjustment in male long-term survivors of bone marrow transplantation. PubMed ·Alex Molassiotis, Olga van den Akker, D Milligan, B. J. Boughton	1995	36
19	The addition of arsenic trioxide to low-dose Ara-C in older patients with AML does not improve outcome Leukemia ·Alan K. Burnett, Robert K. Hills, Ann Hunter, D Milligan, Jonathan Kell, Keith Wheatley, J. A. Liu Yin, MF Mcmullin, Paul Cahalin, J Craig, David Bowen, Nigel H. Russell	2011	35
20	CAMPATH-1 antibodies in stem-cell transplantation Cytotherapy ·G Hale, Stephen Cobbold, Nicolás Novitzky, Donald Bunjes, R. Willemze, H. G. Prentice, D Milligan, Stephen Mackinnon, Herman Waldmann	2001	35

About D Milligan

D Milligan is a scholar working on Hematology, Genetics, Transplantation, Pathology and Forensic Medicine and Immunology, having authored 62 papers that have together received 3.0k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (16 papers), Lymphoma Diagnosis and Treatment (14 papers), Acute Myeloid Leukemia Research (12 papers), Hematopoietic Stem Cell Transplantation (12 papers), Acute Lymphoblastic Leukemia research (9 papers), Chronic Myeloid Leukemia Treatments (6 papers), Immunodeficiency and Autoimmune Disorders (5 papers) and Childhood Cancer Survivors' Quality of Life (5 papers). The work is most often cited by research in Hematology (1.1k citations), Genetics (1.0k citations), Pathology and Forensic Medicine (1.4k citations), Oncology (1.1k citations) and Neurology (371 citations). D Milligan has collaborated with scholars based in United Kingdom, Germany and France. Frequent co-authors include Barry W. Hancock, G. Vaughan Hudson, David C. Linch, D.A. Winfield, A. H. Goldstone, D. J. Moir, Rajesh Chopra, Annabel McMillan, Rosemary A. Barnes and J. M. Davies. Their work appears in journals such as Leukemia, British Journal of Haematology, Bone Marrow Transplantation, Journal of Clinical Pathology and Psycho-Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact